TARDBP and neurodegenerative disease: While primarily a pathological feature in ALS and FTD, the abnormal deposition of TDP-43 has also been reported across the spectrum of neurodegenerative diseases including Alzheimer’s disease (AD) [40], Parkinson’s disease (PD) [41] Huntington’s disease [42] and CTE [43].